TOT BIOPHARM Co Ltd
http://www.totbiopharm.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From TOT BIOPHARM Co Ltd
China Biotech Podcast: BIOSECURE Updates, Genmab/ProfoundBio Deal
In this mixed Chinese- and English-language episode, guest speaker Treehill Partners co-founder Ali Pashadezah joins Brian Yang and Dexter Yan to discuss updates on the proposed BIOSECURE Act in the US Congress and US-China biotech movements. Also discussed is how Chinese biotechs are becoming acquisition targets for overseas biotech companies, including the recent purchases of Profound by Genmab and AnHeart Theraputics by Nuvantion.
Merck KGaA Looks To Build Cancer ADCs With Caris’s AI Technology
Deal snapshot: The German biopharma will partner with Caris’s research arm to discover and validate novel targets for incorporation into first-in-class antibody-drug conjugates for cancer.
Genmab And Merck Ramp Up ADC Competition In Ovarian Cancer
Genmab is the latest company to join an escalating arms race in antibody-drug conjugates, challenging AbbVie’s lead in ovarian cancer treatment.
Genmab Adds To Sector ADC Buying Spree With $1.8bn ProfoundBio Acquisition
The buyout reflects the Danish biotech’s plans to expand in oncology drug development and commercialization.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice